Cargando…
Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
BACKGROUND: Despite enormous progress in elucidating the biophysics of aggregation, no cause-and-effect relationship between protein aggregation and neurodegenerative disease has been unequivocally established. Here, we derived several risk-based stochastic kinetic models that assess genotype/phenot...
Autores principales: | Sugaya, Keizo, Matsubara, Shiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468392/ https://www.ncbi.nlm.nih.gov/pubmed/22583646 http://dx.doi.org/10.1186/1750-1326-7-20 |
Ejemplares similares
-
Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases
por: Sugaya, Keizo, et al.
Publicado: (2009) -
Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset
por: Sugaya, Keizo, et al.
Publicado: (2007) -
Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
por: Khare, Sagar D, et al.
Publicado: (2005) -
Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington’s disease model system
por: Xi, Wen, et al.
Publicado: (2016) -
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases
por: Popiel, H. Akiko, et al.
Publicado: (2011)